The company is engaged in research, development, production and sales of APIs and intermediates. The company's capacities: laboratory, joint pharmaceutical enterprises (GMP). The main services are CDMO, laboratory research, development, production of raw materials and intermediates, supply of pharmaceutical equipment, etc. The company operates in China and abroad. Export to more than 100 countries (USA, Canada, Germany, Spain, Australia, Russia, UAE, Estonia, Indonesia, Egypt, Pakistan, etc.).